We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
(+3.3%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$122M |
| 3 |
Alerian MLP ETF
AMLP
|
+$112M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.3M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$75.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$92.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$49.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$25.4M |
| 4 |
Schwab US REIT ETF
SCHH
|
+$23.4M |
| 5 |
Apple
AAPL
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.77% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 1.86% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
X
351
DELISTED
US Steel
X
| $3.63M | 0.01% |
314,711
-181,242
| -37% | -$2.33M |
|
352
Linde
LIN
$237B
| $3.59M | 0.01% |
18,555
+1,084
| +6% | +$210K |
|
353
iShares Biotechnology ETF
IBB
$9.31B
| $3.59M | 0.01% |
36,106
-648
| -2% | -$67.8K |
|
354
W.P. Carey
WPC
$17.1B
| $3.58M | 0.01% |
40,878
+2,868
| +8% | +$244K |
|
355
United Bankshares
UBSI
$6.55B
| $3.56M | 0.01% |
94,107
-2,303
| -2% | -$85.3K |
|
356
Nuveen ESG Mid-Cap Value ETF
NUMV
$445M
| $3.53M | 0.01% |
121,558
+2,463
| +2% | +$69.9K |
|
357
Nuveen ESG Mid-Cap Growth ETF
NUMG
$343M
| $3.53M | 0.01% |
107,834
+2,106
| +2% | +$69.8K |
|
358
Essential Utilities
WTRG
$11.2B
| $3.52M | 0.01% |
78,504
-2,857
| -4% | -$123K |
|
359
Idexx Laboratories
IDXX
$42.9B
| $3.52M | 0.01% |
12,926
-8,805
| -41% | -$2.45M |
|
|
IMMU
360
DELISTED
Immunomedics Inc
IMMU
| $3.47M | 0.01% |
261,455
+18,927
| +8% | +$278K |
|
361
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
| $3.45M | 0.01% |
51,814
-1,729
| -3% | -$115K |
|
|
SCHW
362
Charles Schwab
SCHW
$177B
| $3.45M | 0.01% |
82,552
-4,031
| -5% | -$163K |
|
363
Delta Air Lines
DAL
$55.9B
| $3.45M | 0.01% |
59,935
-11,307
| -16% | -$670K |
|
364
Arbor Realty Trust
ABR
$960M
| $3.45M | 0.01% |
263,043
+241,112
| +1,099% | +$3.01M |
|
365
Regeneron Pharmaceuticals
REGN
$68.8B
| $3.39M | 0.01% |
12,209
+201
| +2% | +$59.5K |
|
366
Parker-Hannifin
PH
$125B
| $3.34M | 0.01% |
18,506
+267
| +1% | +$45.4K |
|
|
MDCO
367
DELISTED
Medicines Co
MDCO
| $3.34M | 0.01% |
66,742
-9,500
| -12% | -$379K |
|
368
Tapestry
TPR
$28.8B
| $3.34M | 0.01% |
128,043
+76,191
| +147% | +$2.01M |
|
369
Blackrock
BLK
$164B
| $3.33M | 0.01% |
7,476
-312
| -4% | -$139K |
|
370
Welltower
WELL
$178B
| $3.32M | 0.01% |
36,628
+312
| +0.9% | +$27.1K |
|
371
Stanley Black & Decker
SWK
$14.2B
| $3.3M | 0.01% |
22,871
+531
| +2% | +$75K |
|
372
HCI Group
HCI
$2.28B
| $3.29M | 0.01% |
78,142
-2,500
| -3% | -$103K |
|
373
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $3.28M | 0.01% |
53,801
-2,382
| -4% | -$145K |
|
374
Clorox
CLX
$11.6B
| $3.25M | 0.01% |
21,389
+2,955
| +16% | +$467K |
|
375
Edison International
EIX
$30.7B
| $3.24M | 0.01% |
42,904
+1,201
| +3% | +$86.4K |
|
Similar funds
Creative Planning's Q3 2019 Portfolio in Review
As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.
- Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
- Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
- Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
- Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
- Creative Planning opened 164 new positions and closed 188 in Q3 2019.
- Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.
Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.